Equity News

Chico’s Shares Rise Despite Lowering of Full-Year Sales Guidance

Chico’s Shares Rise Despite Lowering of Full-Year Sales Guidance

Chico’s FAS (CHS) shares popped more than 15% on Tuesday after the fashion retailer lowered its full-year sales guidance but posted better-than-expected fiscal first-quarter results. The Fort Myers, Fla.-based company, which also operates the White House Black Market and Soma brands, said it now expects a low to mid-single digit decline in total net sales and comparable sales in the […]

Chipmakers Lifting Tech Stocks to Outsized Advance

Chipmakers Lifting Tech Stocks to Outsized Advance

Top Tech Stocks IBM +3.05% AAPL +2.99% CSCO +2.39% MSFT +1.64% GOOG +1.61% Technology stocks were helping lead Tuesday’s equity market recovery, with the shares of tech stocks in the S&P 500 climbing 1.7% while the Philadelphia Semiconductor Index was rising 3.4%. Among technology stocks moving on news: (+) ASGN Inc (ASGN) climbed 6.6% after the IT staffing firm announced […]

Proxy Advisory Firm ISS Backs Nominees from Bow Street for Mack-Cali Realty Board

Proxy Advisory Firm ISS Backs Nominees from Bow Street for Mack-Cali Realty Board

Investment firm Bow Street, mired in a proxy fight with Mack-Cali Realty (CLI), said on Friday independent proxy advisory firm Institutional Shareholder Services (ISS) has recommended Mack-Cali shareholders to vote for Bow’s three nominees to the board at the shareholders’ meeting on June 12. “[Bow Street] has presented a compelling case that the replacement of several long-tenured directors with independent […]

DelMar Pharma Shares Rally More Than 180% After Interim Trial Results of VAL-083 Update at ASCO

DelMar Pharma Shares Rally More Than 180% After Interim Trial Results of VAL-083 Update at ASCO

DelMar Pharmaceuticals (DMPI) shares rallied more than 180% on Friday after the company gave an encouraging update to its first- and second-line mid-stage trials of VAL-083 in patients with MGMT-unmethylated glioblastoma multiforme at the annual ASCO cancer meeting in Chicago. For the front-line treatment of the drug with radiation therapy, the trial showed eight patients getting a “complete response” and […]